We are live on ! Find out more
PP

Paloma Partners Portfolio holdings

AUM $510M
1-Year Est. Return 286.05%
This Fund
S&P 500
This Quarter Est. Return
-12.73%
1 Year Est. Return
+286.05%
3 Year Est. Return
+321.92%
5 Year Est. Return
+284.54%
10 Year Est. Return
+855.7%
AUM
$3.27B
AUM Growth
-$2.23B
Cap. Flow
-$1.59B
Cap. Flow %
-48.72%
Top 10 Hldgs %
31.35%
Holding
2,012
New
555
Increased
282
Reduced
355
Closed
799

Top Sells

Rank Stock Value
1
ANDV
Andeavor
ANDV
+$360M
2
UNP icon
Union Pacific
UNP
+$47.4M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$41M
4
CMCSA icon
Comcast
CMCSA
+$40.6M
5
DIS icon
Walt Disney
DIS
+$39.1M

Sector Composition

Rank Sector Weight
1 Technology 9.63%
2 Financials 8.31%
3 Healthcare 5.75%
4 Industrials 4.11%
5 Consumer Discretionary 4.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MBII
1126
DELISTED
Marrone Bio Innovations, Inc.
MBII
$73K ﹤0.01%
+49,500
New +$75.8K
CMRX
1127
DELISTED
Chimerix, Inc.
CMRX
$71K ﹤0.01%
+27,700
New +$92.7K
AWRE icon
1128
Aware
AWRE
$24.5M
$70K ﹤0.01%
+19,500
New +$70.6K
PEI
1129
DELISTED
Pennsylvania Real Estate Investment Trust
PEI
$70K ﹤0.01%
789
-1,398
-64% -$174K
CYH icon
1130
Community Health Systems
CYH
$385M
$69K ﹤0.01%
24,400
+14,240
+140% +$48.9K
STGW icon
1131
Stagwell
STGW
$2.01B
$69K ﹤0.01%
26,282
+14,382
+121% +$40.9K
ARDX icon
1132
Ardelyx
ARDX
$1.25B
$66K ﹤0.01%
+36,800
New +$108K
BGC icon
1133
BGC Group
BGC
$5.66B
$66K ﹤0.01%
+12,845
New +$84.6K
INO icon
1134
Inovio Pharmaceuticals
INO
$85.6M
$65K ﹤0.01%
1,350
+377
+39% +$22.9K
BLCM
1135
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$65K ﹤0.01%
+2,240
New +$99.4K
CBL
1136
DELISTED
CBL& Associates Properties, Inc.
CBL
$65K ﹤0.01%
+33,700
New +$98.8K
NCSM icon
1137
NCS Multistage Holdings
NCSM
$117M
$64K ﹤0.01%
+630
New +$121K
MGI
1138
DELISTED
MoneyGram International, Inc. New
MGI
$64K ﹤0.01%
32,200
+1,800
+6% +$5.79K
BRS
1139
DELISTED
Bristow Group, Inc.
BRS
$63K ﹤0.01%
+25,946
New +$197K
INSE icon
1140
Inspired Entertainment
INSE
$185M
$62K ﹤0.01%
12,955
-6,880
-35% -$42.7K
SUP
1141
DELISTED
Superior Industries International
SUP
$62K ﹤0.01%
12,805
-14,325
-53% -$133K
AVDL
1142
DELISTED
Avadel Pharmaceuticals
AVDL
$59K ﹤0.01%
+22,970
New +$78.1K
SAN icon
1143
Banco Santander
SAN
$194B
$59K ﹤0.01%
+13,834
New +$62.7K
RAD
1144
DELISTED
Rite Aid Corporation
RAD
$59K ﹤0.01%
4,130
+730
+21% +$15.4K
JNCE
1145
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$59K ﹤0.01%
+17,500
New +$81.8K
CRVS icon
1146
Corvus Pharmaceuticals
CRVS
$1.12B
$58K ﹤0.01%
+15,900
New +$108K
CX icon
1147
Cemex
CX
$17.1B
$57K ﹤0.01%
+11,694
New +$62.4K
VSLR
1148
DELISTED
VIVINT SOLAR, INC.
VSLR
$57K ﹤0.01%
+14,900
New +$76.9K
GSIT icon
1149
GSI Technology
GSIT
$208M
$56K ﹤0.01%
10,856
-18,262
-63% -$107K
SNDX icon
1150
Syndax Pharmaceuticals
SNDX
$1.74B
$56K ﹤0.01%
+12,500
New +$68.5K

Similar funds

Paloma Partners's Q4 2018 Portfolio in Review

As of Q4 2018, Paloma Partners held 2,012 positions worth $3.27B, down 41% from $5.5B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Paloma Partners withdrew a net $1.59B in Q4 2018, closing 799 positions and reducing 355 holdings. Its most notable exit was Andeavor, an estimated $360M position sold in full.

By sector, the portfolio is most concentrated in Technology at 9.6% of assets, up from 8.3% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Paloma Partners opened a new position in Chaparral Energy, Inc. worth $10.5M.

  • Paloma Partners's largest Q4 2018 buy was Chaparral Energy, Inc.: 2,131,177 shares worth $10.5M.
  • Paloma Partners added most to State Street Energy Select Sector SPDR ETF in Q4 2018, an estimated $117M increase.
  • Paloma Partners's biggest Q4 2018 reduction was Union Pacific, cutting an estimated $47.4M.
  • Paloma Partners fully exited Andeavor in Q4 2018, selling an estimated $360M.
  • Paloma Partners's ten largest holdings make up 31% of its $3.27B portfolio in Q4 2018.
  • Paloma Partners opened 555 new positions and closed 799 in Q4 2018.
  • Paloma Partners's portfolio value fell 41% quarter-over-quarter to $3.27B.

Based on Paloma Partners's 13F filing for Q4 2018, filed 14 Feb 2019.